News

'Coaching' Fails to Improve Diabetes in Disadvantaged Patients

View on the News

Disadvantaged Patients Eager to Engage

The most significant finding by Frosch et al is that a telephone "coaching" intervention was feasible and well received "by even the most socially and economically disadvantaged" patients, said Ruth Q. Wolever, Ph.D., and Dr. David M. Eisenberg.

A total of 94% of patients viewed the educational DVD; 85% assigned to telephone coaching participated in it, and 73% of them completed all five sessions. This indicates "a desire for diabetes self-management education and a willingness to engage in such interventions. Importantly, these results directly challenge the perception that individuals of lower socioeconomic status may be less motivated to learn self-care strategies," they said.

Dr. Wolever and Dr. Eisenberg are in psychiatry and behavioral sciences at Duke University Medical Center, Durham, N.C. They reported no financial conflicts of interest. These remarks were taken from their invited commentary accompanying Dr. Frosch’s report (Arch. Intern. Med. 2011 Oct. 10 [doi:10.1001/archinternmed.2011.508]).


 

FROM ARCHIVES OF INTERNAL MEDICINE

This study was supported by the Robert Wood Johnson Foundation, the Foundation for Informed Medical Decision Making, the National Institute on Aging, and the National Institutes of Health. Dr. Frosch reported receiving honoraria from the Foundation for Informed Medical Decision Making.

Pages

Recommended Reading

Intensive Glucose-Lowering Does Not Benefit Cognition
MDedge Internal Medicine
Heart Failure Doubles 5-Year Fracture Risk
MDedge Internal Medicine
Teriparatide Now Preferred Drug for Steroid-Induced Osteoporosis
MDedge Internal Medicine
Rheumatologists 'Pretty Good' at Treating Steroid-Induced Osteoporosis
MDedge Internal Medicine
Obesity May Explain Liver Cancer Hike Among Latinos
MDedge Internal Medicine
Conventional LFTs Often Miss Liver Disease in Type 2 Diabetes
MDedge Internal Medicine
Small Changes Count in Type 2 Diabetes Patients
MDedge Internal Medicine
FDA Approves Juvisync for Diabetes, High Cholesterol
MDedge Internal Medicine
Investigational Chemokine Receptor Reduces Hemoglobin A1c
MDedge Internal Medicine
Gastric Bypass's Metabolic Gains Persist at 6 Years
MDedge Internal Medicine